Urothelial Bladder Cancer
Showing 1 - 25 of >10,000
Muscle Invasive Bladder Cancer, Urothelial Carcinoma Trial in Tianjin (Tislelizumab, Nab paclitaxel)
Active, not recruiting
- Muscle Invasive Bladder Cancer
- Urothelial Carcinoma
- Tislelizumab
- Nab paclitaxel
-
Tianjin, Tianjin, ChinaTianjin Medical University Second Hospital
Nov 23, 2022
Intermediate and High-Risk Bladder Cancer Patients
Recruiting
- Urothelial Bladder Cancer
- CxBladder Monitor
-
White River Junction, Vermont
- +1 more
Sep 12, 2022
Urothelial Carcinoma, Bladder Cancer Trial in Rotterdam, Utrecht (Ipilimumab + nivolumab)
Active, not recruiting
- Urothelial Carcinoma
- Bladder Cancer
- Ipilimumab + nivolumab
-
Rotterdam, Netherlands
- +1 more
Apr 14, 2022
Muscle Invasive Bladder Cancer Urothelial Carcinoma Trial in Tianjin (Tislelizumab Nab paclitaxel)
Recruiting
- Muscle Invasive Bladder Cancer Urothelial Carcinoma
- Tislelizumab Nab paclitaxel
-
Tianjin, Tianjin, Chinaianjin Medical University Second Hospital
Jun 8, 2022
Urothelial Carcinoma Bladder, Androgen Receptor Positive Trial in Providence (Degarelix, Gemcitabine/Cisplatin)
Not yet recruiting
- Urothelial Carcinoma Bladder
- Androgen Receptor Positive
- Degarelix
- Gemcitabine/Cisplatin
-
Providence, Rhode IslandLifespan Cancer Institute
May 1, 2023
Biomarkers in Bladder Urothelial Carcinoma
Completed
- Bladder Cancer
- Free glycosaminoglycan profiling
-
Gothenburg, SwedenDepartment of Urology, Institute of Clinical Science, Sahlgrensk
Apr 3, 2023
Urothelial/Bladder Cancer, Nos Trial in New York (Atezolizumab, PGV001, Poly ICLC)
Completed
- Urothelial/Bladder Cancer, Nos
- Atezolizumab
- +3 more
-
New York, New YorkIcahn School of Medicine at Mount Sinai
Mar 7, 2022
Locally Advanced Bladder Urothelial Carcinoma, Locally Advanced Renal Pelvis Urothelial Carcinoma, Locally Advanced Ureter
Not yet recruiting
- Locally Advanced Bladder Urothelial Carcinoma
- +31 more
- Diagnostic Laboratory Biomarker Analysis
- Nivolumab
-
Houston, TexasM D Anderson Cancer Center
Aug 18, 2022
Protocol for Muscle Invasive Urothelial Carcinoma of Urinary
Recruiting
- Bladder Cancer
- terta modal bladder preservation
-
Assiut, Assuit, EgyptAssuit university
Aug 13, 2022
Muscle Invasive Bladder Carcinoma, Stage II Bladder Cancer AJCC v8, Stage IIIA Bladder Cancer AJCC v8 Trial in Seattle
Recruiting
- Muscle Invasive Bladder Carcinoma
- +2 more
- Lymphadenectomy
- +2 more
-
Seattle, WashingtonFred Hutch/University of Washington Cancer Consortium
Jan 9, 2023
High Grade Urothelial Carcinoma, Bladder Cancer, Urothelial Carcinoma Bladder Trial in Washington, Baltimore (Enfortumab
Not yet recruiting
- High Grade Urothelial Carcinoma
- +2 more
- Enfortumab vedotin
- Pembrolizumab
-
Washington, District of Columbia
- +1 more
Jan 5, 2023
Analytical Specificity of Bladder EpiCheck Test in Healthy
Completed
- Non Muscle Invasive Bladder Cancer
- Non-Muscle Invasive Bladder Urothelial Carcinoma
- Bladder EpiCheck
-
San Antonio, TexasUrology San Antonio
Sep 3, 2023
Avelumab First-Line Maintenance in Canadian People With Advanced
Not yet recruiting
- Urinary Bladder Neoplasms
- +3 more
- Avelumab first-line maintenance
-
Mississauga, Ontario, CanadaBayshore Specialty Rx
Jan 24, 2023
Urothelial Carcinoma, Non-Invasive Bladder Urothelial Carcinoma Trial in Tampa (Adoptive Cell Therapy with Tumor-infiltrating
Recruiting
- Urothelial Carcinoma
- Non-Invasive Bladder Urothelial Carcinoma
- Adoptive Cell Therapy with Tumor-infiltrating Lymphocytes (TIL)
-
Tampa, FloridaMoffitt Cancer Center
Mar 2, 2023
Bladder Cancer, Urothelial Carcinoma, Hematuria Trial (Urinalysis)
Not yet recruiting
- Bladder Cancer
- +3 more
- Urinalysis
- (no location specified)
Dec 1, 2022
Urothelial Cancer and Rare Genitourinary Tract Malignancies
Recruiting
- Urothelial Cancer
- +4 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center
Jan 23, 2023
Neutrophils to Lymphocytes Ratio in Predicting Response to BCG
Completed
- Urinary Bladder Cancer
- +4 more
- Neutrophil to lymphocyte ratio
-
Cairo, EgyptAin Shams university
Jul 15, 2023
Metastatic Urothelial Carcinoma Trial (Pembrolizumab (200mg), Pembrolizumab (400mg), Monitoring)
Not yet recruiting
- Metastatic Urothelial Carcinoma
- Pembrolizumab (200mg)
- +2 more
- (no location specified)
Sep 18, 2023
Bladder Cancer Trial in Lausanne (Flexible cystoscopy, Urinary catheter)
Active, not recruiting
- Bladder Cancer
- Flexible cystoscopy
- Urinary catheter
-
Lausanne, VD, SwitzerlandCentre Hospitalier Universitaire Vaudois, CHUV
Dec 1, 2022
Muscle Invasive Bladder Urothelial Carcinoma, Stage II Bladder Urothelial Carcinoma AJCC v6 and v7, Stage III Bladder Urothelial
Not yet recruiting
- Muscle Invasive Bladder Urothelial Carcinoma
- +3 more
- Biospecimen Collection
- +7 more
- (no location specified)
Aug 10, 2023
Urothelial Carcinoma Ureter, Urothelial Cancer of Renal Pelvis Trial (Mitomycin C)
Not yet recruiting
- Urothelial Carcinoma Ureter
- Urothelial Cancer of Renal Pelvis
- Mitomycin C
- (no location specified)
Jul 31, 2023
Hydronephrosis, Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant, Infiltrating Bladder Urothelial Carcinoma,
Active, not recruiting
- Hydronephrosis
- +18 more
- Durvalumab
- +2 more
-
Houston, TexasM D Anderson Cancer Center
Oct 31, 2022
Care of Urothelial Cancer Patient and Prospective Procurement of
Recruiting
- Bladder Cancer
- +3 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Hematuria, Urothelial Tumor, Urothelial Carcinoma Trial in Rotterdam (urine-first strategy)
Recruiting
- Hematuria
- +3 more
- urine-first strategy
-
Rotterdam, NetherlandsSeARCH-trial Pijpers
Aug 30, 2023
Liquid Biospy for Urinary Cancers
Recruiting
- Urothelial Carcinoma
- Genetic analysis on isolated cells
-
Milan, ItalyUrology Department
Nov 6, 2023